EIT Health Catapult Finalists 2020

Zoan BioMed is delighted to announce it was successful in today’s semi final of the EIT Health Catapult Programme – earning its place in the final later this year. The line up of 40 semi finalists across MedTech, BioTech and Digital Health represent some of the most exciting innovations in healthcare across Europe today. Zoan BioMed’s achievement of its place in the final is further demonstration of its continued path towards commercialisation in 2021. We look forward to the next opportunity to showcase the opportunities that our platform offers.

We would like to thank EIT for its continued support and mentorship and look forward to our future collaborations together.

The finals take place in December and you can register to attend the finals as part of EIT’s Health Summit here.

EIT Health is supported by the European Institute of Innovation and Technology, a body of the European Union, to find out more visit https://eithealth.eu/

Latest News

Derek Cawley joins Zoan Biomed Advisory team

Zoan Biomed are delighted to announce Derek Cawley as an advisor to the company as they continue to strengthen the team. Derek works as a spine surgeon in Dublin, Ireland (www.thespineacademy.ie). He completed spine fellowships at CHU Bordeaux, France and RNOH Stanmore, UK. Awards include the BOA ZimmerTrauma, Eurospine, Ethicon, Mark Paterson and EFORT travelling fellowships. Derek…

Roger Sloan

Zoan Biomed are delighted to announce Roger Sloan as an advisor to the company as they continue to strengthen the team.  Roger Sloan is an active Consultant Orthopaedic Surgeon at South Warwickshire Hospitals, UK. He was brought up in Holywood, Northern Ireland, trained at Edinburgh Medical School and completed specialist orthopaedic training occurring at Oswestry,…

European Maritime Day

Zoan BioMed was the first company to be introduced at the conference – ‘Bringing Blue Innovation to the Market’. We presented our business and detailed our commercialisation plans after FDA approval. Of particular interest was the sustainability credentials of the Zoan BioMed platform – the first company in its industry to commit towards a short…

Martin Johnson joins Zoan Biomed to lead development of its 3D Printing proposition

Martin leads the development of Zoan’s portfolio of 3D printable materials and medical devices in partnership with industry incumbents and research centres. He brings deep R&D experience with his work with WWF and the Dutch Environment Ministry building on 15+ years’ experience in marine biogeochemisty research at the University of East Anglia.  Other areas of expertise…

Contact Us

To find out more about Zoan BioMed get in touch